Detalhe da pesquisa
1.
Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
J Allergy Clin Immunol
; 147(2): 704-712.e17, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32745555